$6.41
15.08% yesterday
NYSE, Apr 07, 10:14 pm CET
ISIN
US37611X1000
Symbol
DNA

Ginkgo Bioworks Target price 2025 - Analyst rating & recommendation

Ginkgo Bioworks Classifications & Recommendation:

Buy
17%
Hold
17%
Sell
67%

Ginkgo Bioworks Price Target

Target Price $8.60
Price $6.41
Potential
Number of Estimates 5
5 Analysts have issued a price target Ginkgo Bioworks 2026 . The average Ginkgo Bioworks target price is $8.60. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 6 analysts: 1 Analysts recommend Ginkgo Bioworks to buy, 1 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Ginkgo Bioworks stock has an average upside potential 2026 of . Most analysts recommend the Ginkgo Bioworks stock at Sale.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 227.04 174.36
9.71% 23.20%
EBITDA Margin -174.98% -111.68%
26.75% 36.18%
Net Margin -238.48% -190.62%
36.45% 20.07%

6 Analysts have issued a sales forecast Ginkgo Bioworks 2025 . The average Ginkgo Bioworks sales estimate is

$174m
Unlock
. This is
23.20% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$179m 21.16%
Unlock
, the lowest is
$171m 24.70%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $227m 9.71%
2025
$174m 23.20%
Unlock
2026
$204m 17.04%
Unlock
2027
$230m 12.53%
Unlock

5 Analysts have issued an Ginkgo Bioworks EBITDA forecast 2025. The average Ginkgo Bioworks EBITDA estimate is

$-195m
Unlock
. This is
51.26% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-105m 73.80%
Unlock
, the lowest is
$-294m 26.49%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-397m 33.86%
2025
$-195m 50.98%
Unlock
2026
$-80.1m 58.85%
Unlock
2027
$-31.8m 60.29%
Unlock

EBITDA Margin

2024 -174.98% 26.75%
2025
-111.68% 36.18%
Unlock
2026
-39.27% 64.84%
Unlock
2027
-13.86% 64.71%
Unlock

2 Ginkgo Bioworks Analysts have issued a net profit forecast 2025. The average Ginkgo Bioworks net profit estimate is

$-332m
Unlock
. This is
39.08% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-291m 46.71%
Unlock
, the lowest is
$-374m 31.45%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-541m 42.62%
2025
$-332m 38.62%
Unlock
2026
$-252m 24.19%
Unlock

Net Margin

2024 -238.48% 36.45%
2025
-190.62% 20.07%
Unlock
2026
-123.48% 35.22%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -10.54 -6.47
42.62% 38.61%
P/E negative
EV/Sales 1.45

2 Analysts have issued a Ginkgo Bioworks forecast for earnings per share. The average Ginkgo Bioworks EPS is

$-6.47
Unlock
. This is
39.08% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-5.66 46.70%
Unlock
, the lowest is
$-7.28 31.45%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-10.54 42.62%
2025
$-6.47 38.61%
Unlock
2026
$-4.91 24.11%
Unlock

P/E ratio

Current -0.60 74.47%
2025
-0.99 65.00%
Unlock
2026
-1.31 32.32%
Unlock

Based on analysts' sales estimates for 2025, the Ginkgo Bioworks stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.11 81.25%
2025
1.45 30.77%
Unlock
2026
1.24 14.56%
Unlock
2027
1.10 11.13%
Unlock

P/S ratio

Current 1.55 82.20%
2025
2.02 30.22%
Unlock
2026
1.73 14.56%
Unlock
2027
1.54 11.14%
Unlock

Current Ginkgo Bioworks Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
TD Cowen
Locked
Locked
Locked Sep 20 2024
BTIG
Locked
Locked
Locked Aug 23 2024
Analyst Rating Date
Locked
TD Cowen:
Locked
Locked
Sep 20 2024
Locked
BTIG:
Locked
Locked
Aug 23 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today